Cadrenal Therapeutics holds annual stockholder meeting
Bitget2026/09/29 20:06- Cadrenal Therapeutics held its annual shareholder meeting on Sept. 24, 2026.
- Shareholders backed an amendment to the 2022 Successor Equity Incentive Plan, lifting the share pool by 323,542 to 1,000,000.
- The plan change reflects shareholder authorization only; it does not confirm any awards have been granted.
- Stockholders ratified WithumSmith+Brown as independent registered public accounting firm for the year ending Dec. 31, 2026.
- Approval was also granted to issue up to 960,000 common shares upon exercise of Series C-1 warrants; issuance depends on exercises.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Netflix (NFLX.US) reportedly plans to lay off about 5% of its staff: The streaming giant faces growth pressure and trims its workforce ahead of earnings report.
According to reports, Netflix plans to lay off about 5% of its employees as early as next week.
Citi: Besent May "Slash" Long-term Bond Issuance Next Month, 20-year US Treasury Issuance Could Be Directly Canceled
Citi published a research report indicating that US Treasury Secretary Scott Besant is highly likely to reduce the issuance size of long-term US Treasury bonds, and may even completely cancel the issuance of 20-year Treasury bonds.
Rising energy prices intensify inflation concerns; US Treasury yields increase again, with the 10-year rising to 5.25%.
Persistently high energy prices have intensified market concerns about the inflation outlook and reinforced investor expectations of further interest rate hikes by the Federal Reserve. After experiencing significant volatility earlier this week, U.S. Treasury yields are edging back toward recent highs.
Crypto prices
More
